T. Fong

发表

Comparison of Serum Interleukin-10 (IL-10) Levels Between Normal Volunteers and Patients with Advanced Melanoma

J. Nemunaitis, D. Ando, D. Martineau, 2001, Cancer investigation.

Phase I trial of interferon-γ (IFN-γ) retroviral vector administered intratumorally to patients with metastatic melanoma

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer Gene Therapy.

Generation of a systemic antitumor response with regional intratumoral injections of interferon gamma retroviral vector.

S. Mento, J. Robbins, D. Jolly, 1998, Human gene therapy.

Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis.

N. Maitland, P. Pisa, S. Pettersson, 2002, Human gene therapy.

Regulatory T Cells and Human Myeloid Dendritic Cells Promote Tolerance via Programmed Death Ligand-1

W. Telford, B. Levine, C. June, 2010, PLoS biology.

Macrophage colony-stimulating factor expression in retrovirally transduced cells is dependent upon both the adherence status of the target cells and its 5' flanking untranslated region.

M. Jadus, Q. Dan, N. Hoa, 2005, Biochemical and biophysical research communications.

Characterization Of Bone Marrow Derived CD34+ Cells With Different Mobility Potentials By Micro RNA Fingerprinting

D. Mallinson, D. Weinstein, D. Olijnyk, 2013 .

Fluorescence-Activated Cell Sorting for CGMP Processing of Therapeutic Cells

C. McIntyre, T. Fong, Brian T. Flyg, 2010 .

MCA106 fibrosarcoma cells transduced with granulocyte/macrophage colony‐stimulating factor are not superior to the wild‐type cells in suppressing the growth of hepatic metastases

H. Seigler, X. Dong, S. Pruitt, 1999, Journal of surgical oncology.

In situ hybridization analysis of the age-associated decline in IL-2 mRNA expressing murine T cells.

T. Makinodan, T. Fong, 1989, Cellular immunology.

Cellular, biochemical, and molecular basis of T-cell senescence.

J. Lubinski, T. Makinodan, T. Fong, 1987, Archives of pathology & laboratory medicine.

Nonviral and Viral Gene Transfer Into Different Subsets of Human Dendritic Cells Yield Comparable Efficiency of Transfection

N. Maitland, P. Pisa, A. Lundqvist, 2002, Journal of immunotherapy.

Ablation of Tumor Cells In Vivo by Direct Injection of HSV‐Thymidine Kinase Retroviral Vector and Ganciclovir Therapy

H. Kalthoff, B. Howard, T. Fong, 1999, Annals of the New York Academy of Sciences.

Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors.

B. Howard, F. Burrows, B. Laubert, 1997, Human gene therapy.

Increased binding of IL-2 and increased IL-2 receptor mRNA synthesis are expressed by an NK-like cell line in response to IL-1.

J. Lubinski, J. Yodoi, J. Babbitt, 1988, Journal of immunology.

Introductory remarks--with consideration of a T-cell model for aging in cellular proteins.

T. Makinodan, T. Inamizu, M. Chang, 1985, Basic life sciences.

The erythroid-specific protein cGATA-1 mediates distal enhancer activity through a specialized beta-globin TATA box.

B. Emerson, T. Fong, Timothy C. Fong, 1992, Genes & development.

Erythroid-specific activation and derepression of the chick β-globin promoter in vitro

B. Emerson, J. Nickol, T. Fong, 1989, Cell.

The use and development of retroviral vectors to deliver cytokine genes for cancer therapy.

P. Sheridan, D. Jolly, S. Sauter, 2000, Critical reviews in therapeutic drug carrier systems.

Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-γ retroviral vector in melanoma patients

J. Nemunaitis, D. Hoon, S. Huang, 2000, Cancer Gene Therapy.

Preferential enhancement by 2-mercaptoethanol of IL-2 responsiveness of T blast cells from old over young mice is associated with potentiated protein kinase C translocation.

T Makinodan, T. Makinodan, T C Fong, 1989, Immunology letters.

Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma.

J. Nemunaitis, J. Pippen, W. Meyer, 1999, Human gene therapy.

Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.

J. Nemunaitis, W. Meyer, D. Martineau, 1998, Cancer gene therapy.

Comparative analysis of IFN-γ B7.1 and antisense TGF-β gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

D. Besselsen, E. Akporiaye, J. Kobie, 2001, Cancer Immunology, Immunotherapy.

Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma.

D. Besselsen, E. Akporiaye, J. Kobie, 2001, Cancer immunology, immunotherapy : CII.

Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.

H. Seigler, S. Osanto, D. Jolly, 1997, Cancer gene therapy.

Cryopreserved Ex Vivo-Expanded Allogeneic Myeloid Progenitor Cell Product Protects Neutropenic Mice from a Lethal Fungal Infection

J. Domen, D. Gille, J. Christensen, 2016, Cell transplantation.

Increase in Tac mRNA expression in natural killer-like cell line in response to interleukin-1 and interleukin-2 shown at the population and cellular level by in situ hybridization.

J. Babbitt, E. Bloom, T. Fong, 1989, Natural immunity and cell growth regulation.

Depletion of recipient NK cells significantly increases engraftment of haplo-matched highly purified hematopoietic stem cells

D. Gille, J. Christensen, Stephanie Smith-Berdan, 2006 .

Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanoma.

J. Nemunaitis, M. Pike, D. Ando, 1999, Cancer gene therapy.

Identification of a promoter element that regulates tissue-specific expression of the human CD80 (B7.1) gene.

T. Kipps, Y. Wu, T. Fong, 1996, Journal of immunology.